Lombard Odier Asset Management Europe Ltd Invests $9.53 Million in Chemed Co. (NYSE:CHE)

Lombard Odier Asset Management Europe Ltd purchased a new position in shares of Chemed Co. (NYSE:CHE) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 17,572 shares of the company’s stock, valued at approximately $9,534,000. Lombard Odier Asset Management Europe Ltd owned approximately 0.12% of Chemed as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of Chemed during the fourth quarter valued at approximately $92,359,000. TD Asset Management Inc grew its stake in shares of Chemed by 164.3% during the 4th quarter. TD Asset Management Inc now owns 205,777 shares of the company’s stock valued at $120,328,000 after purchasing an additional 127,934 shares during the period. Thrivent Financial for Lutherans increased its position in Chemed by 300.3% in the second quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company’s stock worth $63,249,000 after buying an additional 87,449 shares in the last quarter. Epoch Investment Partners Inc. increased its holdings in Chemed by 85.2% in the 4th quarter. Epoch Investment Partners Inc. now owns 152,162 shares of the company’s stock worth $88,977,000 after acquiring an additional 70,001 shares in the last quarter. Finally, Impax Asset Management Group plc raised its position in shares of Chemed by 19.5% during the 2nd quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock valued at $172,510,000 after purchasing an additional 51,974 shares during the period. 95.85% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the completion of the sale, the executive vice president now owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the sale, the executive vice president now directly owns 5,990 shares of the company’s stock, valued at $3,363,864.20. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Andrea R. Lindell sold 831 shares of Chemed stock in a transaction on Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the sale, the director now directly owns 5,725 shares in the company, valued at approximately $3,271,894.75. The disclosure for this sale can be found here. Insiders have sold a total of 6,744 shares of company stock worth $3,828,231 in the last ninety days. 3.32% of the stock is owned by insiders.

Chemed Stock Performance

CHE stock opened at $582.06 on Monday. Chemed Co. has a one year low of $497.36 and a one year high of $654.62. The company’s fifty day moving average price is $569.34 and its 200-day moving average price is $577.23. The company has a market capitalization of $8.81 billion, a PE ratio of 31.33, a price-to-earnings-growth ratio of 2.31 and a beta of 0.44.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The firm had revenue of $595.88 million for the quarter, compared to the consensus estimate of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $4.71 earnings per share. On average, research analysts predict that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.34%. This is an increase from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s dividend payout ratio (DPR) is 10.76%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.